CBD showed limited adaptive-functioning differences versus placebo in boys…

Limited Efficacy of Cannabidiol on Adaptive Functioning in Boys with Profound Autism.

Journal of autism and developmental disorders • • Highly Relevant
🤖

AI Summary

This randomized, double-blind study examined whether purified CBD affected adaptive functioning in boys with autism and severe cognitive and behavioral challenges. This abstract reports a secondary outcome measured with the Vineland Adaptive Behavior Scales, Third Edition; standard scores showed a floor effect, so the researchers analyzed raw scores. The treatment comparison was made after 8 weeks of CBD or placebo.

There were no significant between-group differences on most adaptive-functioning measures. The exception was motor skills, where CBD showed superiority to placebo. Compared with their own pre-treatment baselines, boys receiving CBD improved in receptive and written communication raw scores, with near-significant improvement in expressive communication and personal skills; these within-group changes do not establish that CBD caused the improvements. The authors note that future studies need to account for placebo effects and symptom severity and include larger samples and participants with a range of severity. This is an abstract-based summary; the abstract does not report sample size or establish broader clinical benefit.

💡 Key Findings

1
After 8 weeks, there were no significant differences between CBD and placebo on most adaptive-functioning measures.
High
90%
2
CBD showed superiority to placebo on the motor-skills domain, with a significant difference in standard and raw scores.
High
90%
3
Compared with their own pre-treatment baseline, the CBD group improved in raw scores for receptive and written communication; expressive communication and personal skills showed near-significant improvement. These within-group changes do not establish a treatment effect.
High
85%
4
The authors call for larger studies that account for placebo effects and symptom severity and include people with a range of severity.
High
95%

📄 Original Abstract

PURPOSE: This study examined the effect of cannabidiol (CBD) on adaptive functioning in boys with autism and severe cognitive and behavioral challenges using the Vineland Adaptive Behavior Scales, Third Edition (VABS-3). METHODS: Primary outcome measures for a randomized, double-blind study of purified CBD and placebo are available online (Trauner et al., 2025). We now present results of a secondary outcome measure of adaptive functioning in a longitudinal design before and after treatment with CBD or placebo. Raw scores were analyzed after noting a floor effect of standard scores. RESULTS: No significant differences in adaptive functioning, except for motor skills, were found between CBD- and placebo-treated participants after 8 weeks of treatment. When compared to its immediate pre-treatment baseline, CBD (but not placebo) was associated with improvement in raw scores for Receptive and Written communication and showed near-significant improvement in Expressive Communication and Personal Skills. When compared to its immediate pre-treatment baseline, placebo was associated with improvement in Community and worsening of Motor Skills raw scores. There was a significant difference in standard and raw scores between CBD and placebo on the Motor Skills domain, with CBD treatment showing superiority to placebo. CONCLUSIONS: Although no significant between-group differences were found on most measures of adaptive functioning, within-group changes from zero to 8 weeks of treatment with CBD, but not placebo, showed improved communication skills in severely autistic boys. Future studies should account for placebo effects and severity of symptoms, include a larger sample size and individuals with a range of severity.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.